Access to Anti-Obesity Medication for Medicare ...

By Rene Pretorius

December 9, 2024

The Biden administration's proposal to expand anti-obesity medication coverage under ...
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Innovative Pricing and Payment Models for Health Technologies
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
Addressing the Challenges of Value Attribution in Combination Therapies
Global Disparities in Pneumonia Vaccine Access
New Anti-Obesity Medications Should Be Considered Preventive Health Care
Understanding the Cost and Funding of Gene Therapies
The Economic Burden of Liver Transplantation for Hepatitis B in Italy